Obseva

OBSV NASDAQ
10.05
-0.28
-2.71%
After Hours: 10.05 0 0.00% 16:31 07/19 EDT
Open
10.24
Prev Close
10.33
High
10.28
Low
10.05
Volume
8.46K
Avg Vol (3M)
40.41K
52 Week High
19.40
52 Week Low
9.20
% Turnover
0.02%
Market Cap
373.17M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Obseva OBSV stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis (phase 2b of clinical trials) and uterine fibroids (phase 3 of clinical trials); Nolasiban (OBE001), an oral oxytocin receptor antagonist undergoing phase 3 of clinical trials, with the potential to inhibit uterine contractions at the time of embryo transfer, thereby enhancing embryo implantation during assisted reproductive technologies (ART), and OBE022, an oral and selective prostaglandin F2 alpha (PGF2a) receptor antagonist designed to control preterm labor (phase 2a of clinical trials).
MORE >

Recently

Name
Price
%Change